Rilpivirine
Also known as Edurant
Rilpivirine (TMC278, trade name Edurant) is a pharmaceutical drug, developed by Tibotec, for the treatment of HIV infection. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.
Source: WikipediaWhat is it prescribed for?
Patients are most commonly prescribed rilpivirine to treat rabies, blastomycosis, west nile virus, and pick disease.
What drug interactions are known?
Do not take rilpivirine if you are taking any of the following:
Critical Interactions
Significant Interactions
Loading...